You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-beta Catenin (phospho T41 + S45) antibody (ab38511)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-beta Catenin (phospho T41 + S45) antibody
See all beta Catenin products (51) ...

Description

Rabbit polyclonal to beta Catenin (phospho T41 + S45)

Specificity

This antibody is specific for beta Catenin only when phosphorylated at threonine 41 and serine 45.

Tested applications

WB, ELISAmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

Synthetic phosphopeptide derived from Human beta Catenin around the phosphorylation sites of threonine 41 and serine 45.

Positive control

SW626 cell extract.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS (without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

The antibody was affinity purified from rabbit antiserum by affinity chromatography using epitope specific phosphopeptide. The antibody against non phosphopeptide was removed by chromatography using non phosphopeptide corresponding to the phosphorylation site.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - beta Catenin (phospho T41 + S45) antibody (ab38511)Western blot - beta Catenin (phospho T41 + S45) antibody (ab38511) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab38511 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Key dowstream component of the canonical Wnt signaling pathway. In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes.
Involved in the regulation of cell adhesion. The majority of beta-catenin is localized to the cell membrane and is part of E-cadherin/catenin adhesion complexes which are proposed to couple cadherins to the actin cytoskeleton.

Tissue specificity

Expressed in several hair follicle cell types: basal and peripheral matrix cells, and cells of the outer and inner root sheaths. Expressed in colon.

Involvement in disease

Defects in CTNNB1 are associated with colorectal cancer (CRC) [MIM:114500].
Note=Activating mutations in CTNNB1 have oncogenic activity resulting in tumor development. Somatic mutations are found in various tumor types, including colon cancers, ovarian and prostate carcinomas, hepatoblastoma (HB), hepatocellular carcinoma (HCC). HBs are malignant embryonal tumors mainly affecting young children in the first three years of life.
Defects in CTNNB1 are a cause of pilomatrixoma (PTR) [MIM:132600]; a common benign skin tumor.
Defects in CTNNB1 are a cause of medulloblastoma (MDB) [MIM:155255]. MDB is a malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children.
Defects in CTNNB1 are a cause of susceptibility to ovarian cancer (OC) [MIM:167000]. Ovarian cancer common malignancy originating from ovarian tissue. Although many histologic types of ovarian neoplasms have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.
Note=A chromosomal aberration involving CTNNB1 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1.

Sequence similarities

Belongs to the beta-catenin family.
Contains 12 ARM repeats.

Post-translational
modifications

Phosphorylation by GSK3B requires prior phosphorylation of Ser-45 by another kinase. Phosphorylation proceeds then from Thr-41 to Ser-37 and Ser-33.
EGF stimulates tyrosine phosphorylation. Phosphorylation on Tyr-654 decreases CDH1 binding and enhances TBP binding.
Ubiquitinated by the SCF(BTRC) E3 ligase complex when phosphorylated by GSK3B, leading to its degradation. Ubiquitinated by a E3 ubiquitin ligase complex containing UBE2D1, SIAH1, CACYBP/SIP, SKP1, APC and TBL1X, leading to its subsequent proteasomal degradation.

Cellular localization

Cytoplasm. Nucleus. Cytoplasm > cytoskeleton. Cell junction > adherens junction. Cell junction. Cell membrane. Cytoplasmic when it is unstabilized (high level of phosphorylation) or bound to CDH1. Translocates to the nucleus when it is stabilized (low level of phosphorylation). Interaction with GLIS2 and MUC1 promotes nuclear translocation. Interaction with EMD inhibits nuclear localization.

Target information above from: UniProt accessionP35222 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Beta catenin antibody
  • Beta-catenin antibody
  • Cadherin associated protein antibody
  • Catenin (cadherin associated protein), beta 1, 88kDa antibody
  • Catenin beta 1 antibody
  • Catenin beta-1 antibody
  • CATNB antibody
  • CTNB1_HUMAN antibody
  • CTNNB antibody
  • CTNNB1 antibody
  • DKFZp686D02253 antibody
  • FLJ25606 antibody
  • FLJ37923 antibody
  • OTTHUMP00000162082 antibody
  • OTTHUMP00000165222 antibody
  • OTTHUMP00000165223 antibody
  • OTTHUMP00000209288 antibody
  • OTTHUMP00000209289 antibody
see all

Anti-beta Catenin (phospho T41 + S45) antibody images:

  Western blot - beta Catenin (phospho T41 + S45) antibody (ab38511)

Western blot - beta Catenin (phospho T41 + S45) antibody (ab38511)

All lanes : Anti-beta Catenin (phospho T41 + S45) antibody (ab38511) at 1/500 dilution

Lane 1 : SW626 cell extract, pre-incubated with synthesized phosphopeptide.
Lane 2 : SW626 cell extract.

Lysates/proteins at 30 µg per lane.

Secondary
Alkaline Phosphatase AffiniPure Goat Anti-Rabbit IgG (H+L)

Predicted band size : 86 kDa
Observed band size : 60 kDa (why is the actual band size different from the predicted?)


The beta-catenin proteins have many forms. Here for our description, we group them as two forms: native forms and phosphorylated forms. The native forms of beta-catenin proteins show 4-5 protein bands on SDS-PAGE with molecular weights ranging from 80 to 100 kDa. The phosphorylated forms of beta-catenin proteins are the targets and are degradated by the beta-TrCP (beta-transducin repeat containing protein). Beta-TrCP regulates the ubiquitination and thus the degradation of the phosphorylated beta-catenin in the proteasome. The pan beta-catenin antibody recognizes the native forms or non-phosphorylated forms with a major molecular weight of ~ 86 kDa (as stated on SwissProt) and phosphorylated forms or degraded forms with a major band at 60 kDa. This anti-phospho-antibody only recognizes phosphorylated forms or degraded forms with a major band at 60kDa.

References for Anti-beta Catenin (phospho T41 + S45) antibody (ab38511)

ab38511 has not yet been referenced specifically in any publications.

Publishing research using ab38511? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"